 |
| |||
| patient exposure (The estimated exposure to the marketed product, for the period from 1 May 2010 until 30 April 2020, is 45269082 patient-months. tll) | |||
|
| |||
| patient exposure (The estimated exposure to the marketed product, for the period from 1 May 2010 until 30 April 2020, is 45269082 patient-months. tll) | |||